NatureWise Biotech & Medicals Corporation (4732.TWO)

TWD 21.7

(-3.77%)

Market Cap (In TWD)

1.11 Billion

Revenue (In TWD)

160.14 Million

Net Income (In TWD)

10.12 Million

Avg. Volume

29.44 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
21.05-28.6
PE
-
EPS
-
Beta Value
0.823
ISIN
TW0004732003
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Zhong Yang Huang
Employee Count
-
Website
https://www.naturewise.com.tw
Ipo Date
2007-12-31
Details
NatureWise Biotech & Medicals Corporation engages in the development of therapeutic drugs in Taiwan. It offers LipoCol Forte, a capsule for hypercholesterolemia and hypertriglyceridemia; PPL Taiwan green propolis; and NBM-BMX, an oral softgel capsule to treat cancer. The company was founded in 2000 and is based in Taipei, Taiwan.

More Stocks